Facets (new session)
Description
Metadata
Settings
owl:sameAs
Inference Rule:
b3s
b3sifp
dbprdf-label
facets
http://dbpedia.org/resource/inference/rules/dbpedia#
http://dbpedia.org/resource/inference/rules/opencyc#
http://dbpedia.org/resource/inference/rules/umbel#
http://dbpedia.org/resource/inference/rules/yago#
http://dbpedia.org/schema/property_rules#
http://www.ontologyportal.org/inference/rules/SUMO#
http://www.ontologyportal.org/inference/rules/WordNet#
http://www.w3.org/2002/07/owl#
ldp
oplweb
skos-trans
virtrdf-label
None
About:
Macromolecular Antiviral Agents against Zika, Ebola, SARS, and Other Pathogenic Viruses
Goto
Sponge
NotDistinct
Permalink
An Entity of Type :
schema:ScholarlyArticle
, within Data Space :
covidontheweb.inria.fr
associated with source
document(s)
Type:
Academic Article
research paper
schema:ScholarlyArticle
New Facet based on Instances of this Class
Attributes
Values
type
Academic Article
research paper
schema:ScholarlyArticle
isDefinedBy
Covid-on-the-Web dataset
has title
Macromolecular Antiviral Agents against Zika, Ebola, SARS, and Other Pathogenic Viruses
Creator
Münch, Jan
Röcker, Annika
Harms, Mirja
Gajda, Paulina
Tolstrup, Martin
Zuwala, Kaja
Müller, Janis
Riber, Camilla
Zelikin, Alexander
Andersen, Anna
Løvschall, Kaja
Kreppel, Florian
Schandock, Franziska
Source
Medline; PMC
abstract
Viral pathogens continue to constitute a heavy burden on healthcare and socioeconomic systems. Efforts to create antiviral drugs repeatedly lag behind the advent of pathogens and growing understanding is that broad‐spectrum antiviral agents will make strongest impact in future antiviral efforts. This work performs selection of synthetic polymers as novel broadly active agents and demonstrates activity of these polymers against Zika, Ebola, Lassa, Lyssa, Rabies, Marburg, Ebola, influenza, herpes simplex, and human immunodeficiency viruses. Results presented herein offer structure–activity relationships for these pathogens in terms of their susceptibility to inhibition by polymers, and for polymers in terms of their anionic charge and hydrophobicity that make up broad‐spectrum antiviral agents. The identified leads cannot be predicted based on prior data on polymer‐based antivirals and represent promising candidates for further development as preventive microbicides.
has issue date
2017-09-25
(
xsd:dateTime
)
bibo:doi
10.1002/adhm.201700748
bibo:pmid
28945945
has license
no-cc
sha1sum (hex)
c537da32af948fc117eeb863f40ceb8db93c8b87
schema:url
https://doi.org/10.1002/adhm.201700748
resource representing a document's title
Macromolecular Antiviral Agents against Zika, Ebola, SARS, and Other Pathogenic Viruses
has PubMed Central identifier
PMC7161897
has PubMed identifier
28945945
schema:publication
Adv Healthc Mater
resource representing a document's body
covid:c537da32af948fc117eeb863f40ceb8db93c8b87#body_text
is
schema:about
of
named entity 'Viruses'
named entity 'Other'
named entity 'Antiviral Agents'
named entity 'Pathogenic Viruses'
named entity 'HIV-1'
named entity 'LTR'
named entity 'viruses'
named entity 'virus'
named entity 'HIV-1'
named entity 'LTR'
named entity 'anionic'
named entity 'firefly luciferase'
named entity 'infection'
named entity 'polyanions'
named entity 'infection'
named entity 'Ebola'
named entity 'polysaccharides'
named entity 'polymers'
named entity 'Mammalian Cells'
named entity 'SARS'
named entity 'ZIKV'
named entity 'antiviral effect'
named entity 'small molecule drug'
named entity 'polyanion'
named entity 'macromolecules'
named entity 'infection'
named entity 'TMB'
named entity 'plasmids'
named entity 'lipid bilayer'
named entity 'HSV-2'
named entity 'HIV-1 infection'
named entity 'polymers'
named entity 'virus'
named entity 'antiviral activity'
named entity 'hemorrhagic fevers'
named entity 'ZIKV'
named entity 'ZIKV'
named entity 'size-exclusion chromatography'
named entity 'polymers'
named entity 'Sigma-Aldrich'
named entity 'Ebola'
named entity 'env gene'
named entity 'polymers'
named entity 'flow cytometer'
named entity 'polymers'
named entity 'inoculate'
named entity 'polymers'
named entity 'glutamine'
named entity 'supernatant'
named entity 'cell line'
named entity 'CXCR4'
named entity 'polymers'
named entity 'virus'
named entity 'SARS epidemic'
named entity 'viral pathogens'
named entity 'polymer'
named entity 'infection'
named entity 'Glostrup'
named entity 'monomers'
named entity 'infection'
named entity 'Marburg'
named entity 'ZIKV'
named entity 'antiviral activity'
named entity 'Reporter Gene Assay'
named entity 'Live cells'
named entity 'ZIKV'
named entity 'dispersity'
named entity '0.01'
named entity 'BSA'
◂◂ First
◂ Prev
Next ▸
Last ▸▸
Page 1 of 11
Go
Faceted Search & Find service v1.13.91 as of Mar 24 2020
Alternative Linked Data Documents:
Sponger
|
ODE
Content Formats:
RDF
ODATA
Microdata
About
OpenLink Virtuoso
version 07.20.3229 as of Jul 10 2020, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (94 GB total memory)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software